1 day+0.09%
6 months+30.41%
Current year+159.10%
Current year 9.11
Extreme 9.11
23.5
1 year 8.61
Extreme 8.61
23.5
3 years 7.71
Extreme 7.705496
37.95
5 years 7.71
Extreme 7.705496
120.15
10 years 7.71
Extreme 7.705496
1,532.4
Manager TitleAgeSince
Chief Executive Officer 61 01/10/2025
Director TitleAgeSince
Director/Board Member 26 16/06/2026
Director/Board Member - 16/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
13/05/26 Don

Chairman

-13,332 0.2069%
05/05/26 Free

Chairman

4,851 0.0753%
05/05/26 Free

Director

4,851 0.0753%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-.--% - - 15Cr
+0.12%+3.22%+54.92%+125.36% 1,13500Cr
+0.71%+4.68%+39.61%+78.31% 64TCr
+0.01%+1.03%+25.25%+96.69% 50TCr
+1.43%+4.31%+48.28%+67.12% 38TCr
-3.37%-1.99%+59.97%+33.37% 36TCr
-0.41%+2.64%+23.58%+49.82% 29TCr
+0.23%+3.66%+2.45%+23.69% 27TCr
+0.66%+4.00%+51.78%+63.85% 24TCr
+1.33%+3.00%+30.87%+100.85% 19TCr
Average +0.07%+1.60%+37.41%+71.01% 44.49TCr
Weighted average by Cap. +0.06%+1.63%+41.43%+83.39%
Logo Assertio Holdings
Assertio Holdings Inc is a United States-based commercial pharmaceutical company. The Company focused on the marketing and distribution of branded prescription medicines across several therapeutic categories. It maintains a portfolio that includes treatments for neurology disorders, inflammatory conditions, pain management, and oncology. Its activities involve acquiring, licensing, and integrating approved pharmaceutical products, followed by commercialization within the healthcare market. Its operating approach centers on identifying products that have established regulatory clearance and advancing their reach through targeted sales, medical education, and market access efforts. It manages product lifecycles through activities such as labeling updates, supply coordination, and engagement with healthcare professionals and payers.
Employees
53
  1. Stock Market
  2. Stocks
  3. ASRT Stock